Argon Medical Devices has completed its acquisition of the interventional products business of Angiotech Pharmaceuticals Inc., according to a news release.
Argon Medical Devices, based in Plano, Texas, is a manufacturer of specialty medical products, in areas including interventional radiology, vascular surgery, interventional cardiology and critical care procedures. It is a portfolio company of Lake Forest, Il.-based PE firm RoundTable Healthcare Partners.
Angiotech Pharmaceuticals, headquartered in Vancouver, British Columbia, Canada, develops, manufactures and markets medical devices primarily within the areas of interventional oncology, wound closure and ophthalmology.
Financial terms of the acquisition were not disclosed.